Clinical Trials Browser

Phase 1/2 × Carcinoma, Hepatocellular × Electroporation × Clear all

NCT03008343 2019-09-12

Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Hepatocellular